Switzerland to India: Syringe Import Trade Route

The Switzerland to India Syringe corridor is one of India's established pharmaceutical import routes from Switzerland, with 407 shipments documented worth a combined $187.1M USD. The route is dominated by FISHER CLINICAL SERVICES , which alone accounts for roughly 84% of all import value, reflecting the consolidated nature of Switzerland's syringe export sector.

Across 27 active Switzerland suppliers, the average shipment value stands at $459.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 30.4%, placing it at rank #18 among India's top syringe import origins globally.

On the Indian buyer side, key Indian importers include NOVARTIS HEALTHCARE PRIVATE LIMITED , ROCHE PRODUCTS (INDIA) PRIVATE LIMITED , ROCHE PRODUCTS I PRIVATE LIMITED and 12 others. NOVARTIS HEALTHCARE PRIVATE LIMITED is the single largest Indian importer with 39 shipments valued at $159.5M USD.

India's syringe imports from Switzerland are driven primarily by a handful of large-scale Switzerland manufacturers. FISHER CLINICAL SERVICES with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 27 active exporters signals a competitive but concentrated market — Indian buyers benefit from Switzerland supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FISHER CLINICAL SERVICES , F. HOFFMANN -LA ROCHE LTD., , F HOFFMANN-LA ROCHE LIMITED — together account for 96% of total trade value on this route. The average shipment value of $459.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as tqj230 80mg pre-filled syringes 80 mg/0.8ml batch: 2047905 (foc) (clinical trial material) and mircera syringe 0.3ml 100mcg 1 ind make-up methoxy polyethylene glycol-epoetin betalife saving medicine, suggesting that Indian buyers tend to consolidate orders across related product lines from the same Switzerland supplier.

On the buying side, NOVARTIS HEALTHCARE PRIVATE LIMITED is the largest importer with 39 shipments worth $159.5M USD — representing 85% of all syringe imports from Switzerland on this route. A total of 15 buyers are active on this corridor.